Skip to main content

Corporate insider profile

Jason A. Leverone Insider Trades

Latest reported as Chief Financial Officer of OnKure Therapeutics, Inc. (OKUR).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,230.29
Latest transaction
Sep 21, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 21, 2026OnKure Therapeutics, Inc. (OKUR)Chief Financial OfficerSale302$2.97$898.21
Jun 22, 2026OnKure Therapeutics, Inc. (OKUR)Chief Financial OfficerSale303$4.40$1,332